ArticleRheumatology (Oxford, England)2020
Why not to use colchicine in COVID-19? An oldanti-inflammatory drug for a novel auto-inflammatory disease.
Article in Rheumatology (Oxford, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- FRAGILE-COLCOVID19: A Clinical Trial Based on Early Administration of an Oral Combination of Colchicine and Prednisone in Elderly Patients with COVID-19 in Geriatric Facilities.Clinical drug investigation · 2022Trial
- COVID-19 management in patients with comorbid conditions.World journal of virology · 2025Review
- Fighting cytokine storm and immunomodulatory deficiency: By using natural products therapy up to now.Frontiers in pharmacology · 2023Review
- Therapeutic role of immunomodulators during the COVID-19 pandemic- a narrative review.Postgraduate medicine · 2022Review
- Current advancements and future prospects of COVID-19 vaccines and therapeutics: a narrative review.Therapeutic advances in vaccines and immunotherapy · 2022Review
- Severe COVID-19 in pediatric age: an update on the role of the anti-rheumatic agents.Pediatric rheumatology online journal · 2021Review
- Colchicine to Weather the Cytokine Storm in Hospitalized Patients with COVID-19.Journal of clinical medicine · 2020Article
- The efficacy of colchicine in the management of coronavirus disease 2019: A protocol for systematic review and meta-analysis.Medicine · 2020Article
- Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic.Rheumatology international · 2020Article
- Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad.Clinical rheumatology · 2020Review
- The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al.Clinical rheumatology · 2020Article
- Controlling Cytokine Storm Is Vital in COVID-19.Frontiers in immunology · 2020Review
Corrections and comments
- Comment on
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.